These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 2730062)

  • 1. [Malignant progression of oral leukoplakia].
    Inoue A; Uchida M; Kimura Y; Kazaoka N
    Gan To Kagaku Ryoho; 1989 Apr; 16(4 Pt 2-3):1650-6. PubMed ID: 2730062
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Long-term treatment outcome of oral premalignant lesions.
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    Oral Oncol; 2006 May; 42(5):461-74. PubMed ID: 16316774
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral premalignant lesions: is a biopsy reliable?
    Holmstrup P; Vedtofte P; Reibel J; Stoltze K
    J Oral Pathol Med; 2007 May; 36(5):262-6. PubMed ID: 17448135
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Malignant transformation in 1458 patients with potentially malignant oral mucosal disorders: a follow-up study based in a Taiwanese hospital.
    Hsue SS; Wang WC; Chen CH; Lin CC; Chen YK; Lin LM
    J Oral Pathol Med; 2007 Jan; 36(1):25-9. PubMed ID: 17181738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Malignant transformation of oral leukoplakia: a follow-up study of a hospital-based population of 166 patients with oral leukoplakia from The Netherlands.
    Schepman KP; van der Meij EH; Smeele LE; van der Waal I
    Oral Oncol; 1998 Jul; 34(4):270-5. PubMed ID: 9813722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effective management of smoking in an oral dysplasia clinic in London.
    Poate TW; Warnakulasuriya S
    Oral Dis; 2006 Jan; 12(1):22-6. PubMed ID: 16390464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Analysis of relationship between risk factors of malignant transformation of oral leukoplakia and the LSCP system].
    Sun Z; Gong Y; Huang J
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 Sep; 36(5):364-6. PubMed ID: 11769652
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence rates for oral leukoplakia and lichen planus in a Japanese population.
    Nagao T; Ikeda N; Fukano H; Hashimoto S; Shimozato K; Warnakulasuriya S
    J Oral Pathol Med; 2005 Oct; 34(9):532-9. PubMed ID: 16138891
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The malignant transformation of leukoplakia of the oral cavity. A review of the literature and clinical case reports].
    Colella G; De Luca F; Lanza A; Tartaro GP
    Minerva Stomatol; 1995 Jun; 44(6):291-300. PubMed ID: 7476784
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Longitudinal study of TP53 mutations in eight patients with potentially malignant oral mucosal disorders.
    Ogmundsdóttir HM; Hilmarsdóttir H; Björnsson J; Holbrook WP
    J Oral Pathol Med; 2009 Oct; 38(9):716-21. PubMed ID: 19473449
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Carcinoma and dysplasia in oral leukoplakias in Taiwan: prevalence and risk factors.
    Lee JJ; Hung HC; Cheng SJ; Chen YJ; Chiang CP; Liu BY; Jeng JH; Chang HH; Kuo YS; Lan WH; Kok SH
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2006 Apr; 101(4):472-80. PubMed ID: 16545712
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Methylation of p16 CpG island associated with malignant progression of oral epithelial dysplasia: a prospective cohort study.
    Cao J; Zhou J; Gao Y; Gu L; Meng H; Liu H; Deng D
    Clin Cancer Res; 2009 Aug; 15(16):5178-83. PubMed ID: 19671846
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [A white lesion of the oral mucosa: leukoplakia?].
    Gielkens PF; de Visscher JG; van der Waal I
    Ned Tijdschr Geneeskd; 2003 Nov; 147(45):2197-201. PubMed ID: 14640054
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histological and immunochemical studies of oral leukoplakia: phenotype and distribution of immunocompetent cells.
    Bondad-Palmario GG
    J Philipp Dent Assoc; 1995; 47(1):3-18. PubMed ID: 9227108
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CO2 laser treatment of oral leukoplakia.
    Chu FW; Silverman S; Dedo HH
    Laryngoscope; 1988 Feb; 98(2):125-30. PubMed ID: 3123826
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Malignant progression of oral leukoplakia--a long-term follow-up study].
    Inoue A; Sakamoto A; Uchida M; Kamata S
    Nihon Gan Chiryo Gakkai Shi; 1985 Feb; 20(1):18-24. PubMed ID: 3998570
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between clinical and pathologic diagnosis in oral leukoplakia in 54 patients.
    Vázquez-Álvarez R; Fernández-González F; Gándara-Vila P; Reboiras-López D; García-García A; Gándara-Rey JM
    Med Oral Patol Oral Cir Bucal; 2010 Nov; 15(6):e832-8. PubMed ID: 20711115
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metallothionein immunoexpression in oral leukoplakia.
    Johann AC; da Silveira-Júnior JB; Souto GR; Horta MC; Aguiar MC; Mesquita RA
    Med Oral Patol Oral Cir Bucal; 2008 Mar; 13(3):E156-60. PubMed ID: 18305434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of betel quid and cigarette on multistate progression of oral pre-malignancy.
    Yen AM; Chen SC; Chang SH; Chen TH
    J Oral Pathol Med; 2008 Aug; 37(7):417-22. PubMed ID: 18410311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dysplasia as a predictive marker for invasive carcinoma in Barrett esophagus: a follow-up study based on 138 cases from a diagnostic variability study.
    Montgomery E; Goldblum JR; Greenson JK; Haber MM; Lamps LW; Lauwers GY; Lazenby AJ; Lewin DN; Robert ME; Washington K; Zahurak ML; Hart J
    Hum Pathol; 2001 Apr; 32(4):379-88. PubMed ID: 11331954
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.